Bioversys AG (BIOV) — Net Asset Quality Index
Bioversys AG (BIOV) has a Net Asset Quality Index of 66.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CHF90.64 Million minus total liabilities of CHF30.82 Million yields net assets of CHF59.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read BIOV total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bioversys AG Net Asset Quality Index Over Time (2024–2025)
This chart shows how Bioversys AG's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 66.0%, representing net assets of CHF59.81 Million against total assets of CHF90.64 Million CHF. For live market cap and overall valuation, see Bioversys AG stock valuation.
Annual Net Asset Quality Index for Bioversys AG (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Bioversys AG from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See BIOV total equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CHF) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.0% | CHF59.81 Million | CHF90.64 Million | CHF30.82 Million | ▲ +35.4 pp |
| 2024 | 30.6% | CHF10.68 Million | CHF34.96 Million | CHF24.27 Million | — |